|本期目录/Table of Contents|

[1]张伯尧,王军,唐杨烽,等.Del Nido停搏液在急性主动脉夹层手术中的心肌保护作用及对肾功能的影响[J].国际心血管病杂志,2021,05:312-315.
　ZHANG Boyao,WANG Jun,TANG Yangfeng,et al.Effects of Del Nido cardioplegia on myocardial protection and renal function during procedure for acute aortic dissection[J].International Journal of Cardiovascular Disease,2021,05:312-315.
点击复制

Del Nido停搏液在急性主动脉夹层手术中的心肌保护作用及对肾功能的影响(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年05期
页码:
312-315
栏目:
临床研究
出版日期:
2021-10-01

文章信息/Info

Title:
Effects of Del Nido cardioplegia on myocardial protection and renal function during procedure for acute aortic dissection
作者:
张伯尧;王军;唐杨烽;张冠鑫;吴俊;徐志云;韩林
200433 上海,海军军医大学附属第一医院心血管外科
Author(s):
ZHANG Boyao;  WANG Jun;  TANG Yangfeng;  ZHANG Guanxin;  WU Jun;  XU Zhiyun;  HAN Lin
Department of Cardiovascular Surgery, First Affiliated Hospital of Naval Medical University(Second Military Medical University), Shanghai 200433, China
关键词:
急性主动脉夹层;  Del Nido停搏液;  含血停搏液;  血液透析
Keywords:
Acute aortic dissection;  Del Nido cardioplegia;  Cold blood cardioplegia;  Hemodialysis
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.05.014
文献标识码:
-
摘要:
目的:比较Del Nido停搏液与含血停搏液在急性主动脉夹层外科手术中的心肌保护效果及对肾功能的影响。方法:回顾性分析2019年6月至2020年6月因急性主动脉夹层Stanford A型在海军军医大学附属第一医院手术的69例患者,根据术中使用的心脏停搏液分为Del Nido停搏液组(DN组,n=35)和含血停搏液组(CBC组,n=34)。对两组患者术前一般资料、体外循环资料、预后进行比较。结果:两组患者术前一般资料如年龄、性别、心功能、肾功能、高血压及糖尿病患病率的差异无统计学意义。两组患者体外循环时间、主动脉阻断时间、停循环时间、自动复跳率、术后血清肌钙蛋白和肌红蛋白水平的差异无统计学意义。DN组术后死亡3例,需要血液透析9例,CBC组术后死亡4例,需要血液透析5例。 DN组中单侧肾受累患者共14例,其中术后死亡3例,需要血液透析8例; CBC组中单侧肾受累患者共11例,其中术后死亡2例,需要血液透析3例。DN组停搏液灌注次数显著低于CBC组(P<0.05)。两组中单侧肾脏有血供患者的术后透析率、住院天数、死亡率的差异无统计学意义。结论:Del Nido停搏液在急性主动脉夹层Stanford A型外科手术中可以提供较好的心肌保护作用,未对肾功能产生不利影响。
Abstract:
Objective:To observe and compare the effect of Del Nido cardioplegia and cold blood cardioplegia on myocardial protection and renal function in operation for acute aortic dissection.Methods:A retrospective analysis was performed on 69 patients with acute

参考文献/References

[1] 孙立忠. 急性主动脉夹层——我国主动脉外科急需攻克的难关[J]. 中华胸心血管外科杂志, 2014, 30(6):321-322.
[2] Matte GS, Del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children’s Hospital[J]. J Extra Corpor Technol, 2012, 44(3):98-103.
[3] Svensson LG, Gillinov AM, Richard DW, et al. The American Association for Thoracic Surgery Consensus guidelines:reasons and purpose[J]. J Thorac Cardiovasc Surg, 2016, 151(4):935-939.
[4] 傅建学, 王锦鹤, 田发莲, 等. 急性A型主动脉夹层动脉瘤的体外循环管理研究[J]. 心血管外科杂志(电子版), 2019, 8(3):9-10.
[5] Rizoli S. PlasmaLyte[J]. J Trauma, 2011, 70(5 Suppl):S17-S18.
[6] Bito A, Inoue K, Asano M, et al. Experimental myocardial preservation study of adding perfluorochemicals(FC43)in lidocaine cardioplegia[J]. Jpn J Thorac Cardiovasc Surg, 2000, 48(5):280-290.
[7] Brown PS Jr, Holland FW, Parenteau GL, et al. Magnesium ion is beneficial in hypothermic crystalloid cardioplegia[J]. Ann Thorac Surg, 1991, 51(3): 359-367.
[8] Powell WJ, Dibona DR, Flores J, et al. The protective effect of hyperosmotic mannitol in myocardial ischemia and necrosis[J]. Circulation, 1976, 54(4):603-615.
[9] 赵忠新, 邵福源. 甘露醇在急性脑血管疾病时的应用及注意事项[J]. 中国新药与临床杂志, 1999, 18(2):111-113.
[10] Pérez-Pérez AJ, Pazos B, Sobrado J, et al. Acute renal failure following massive mannitol infusion[J]. Am J Nephrol, 2002, 22(5/6):573-575.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2021-10-01